DNase1: No Association with Crohn's Disease in a New Zealand Population

Table 3

DNase1 activity by subphenotype.

		Estimate (95% CI)	P
Age at diagnosis	<17	−0.23 (−4.09–3.64)	0.908
	17 to 40	1.51 (−0.75–3.78)	0.190
	40<	−2.37 (−6.39–1.65)	0.247
CD behaviour	inflammatory	−0.16 (−2.66–2.35)	0.903
	stricturing	1.96 (−1.01–4.93)	0.195
	penetrating	0.88 (−3.32–5.07)	0.681
CD location	Ileal	0.10 (−2.76–2.97)	0.943
	Colonic	1.29 (−1.61–4.19)	0.382
	Ileocolonic	0.38 (−2.69–3.44)	0.809
Other IBD family	Y	0.50 (−4.56–5.57)	0.846
Bowel resection	Y	1.38 (−1.47–4.23)	0.340
EIM	Y	−0.14 (−3.63–3.35)	0.939
Perianal disease	Y	−0.83 (−4.79–3.14)	0.681
severity	Y	1.05 (−2.48–4.59)	0.559
Smoking	Y	1.01 (−3.46–5.65)	0.633